Literature DB >> 34052242

Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.

Aodhán Seán Breathnach1, Christopher James Arthur Duncan2, Kate El Bouzidi3, Aidan Taeke Hanrath4, Brendan Alexander Ingelby Payne2, Paul Anthony Randell5, Maximillian Shahin Habibi6, Peter Andrew Riley7, Timothy David Planche7, John Samuel Busby3, Malur Sudhanva3, Scott John Charles Pallett8, William Peter Kelleher9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34052242     DOI: 10.1016/j.jinf.2021.05.024

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  11 in total

1.  Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.

Authors:  Scott Jc Pallett; Rachael Jones; Ahmed Abdulaal; Mitchell A Pallett; Michael Rayment; Aatish Patel; Sarah J Denny; Nabeela Mughal; Maryam Khan; Carolina Rosadas de Oliveira; Panagiotis Pantelidis; Paul Randell; Christofer Toumazou; Matthew K O'Shea; Richard Tedder; Myra O McClure; Gary W Davies; Luke Sp Moore
Journal:  Euro Surveill       Date:  2022-01

2.  Modelling upper respiratory viral load dynamics of SARS-CoV-2.

Authors:  Joseph D Challenger; Cher Y Foo; Yue Wu; Ada W C Yan; Mahdi Moradi Marjaneh; Felicity Liew; Ryan S Thwaites; Lucy C Okell; Aubrey J Cunnington
Journal:  BMC Med       Date:  2022-01-13       Impact factor: 8.775

3.  A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection.

Authors:  N Kojima; N K Shrestha; J D Klausner
Journal:  Eval Health Prof       Date:  2021-09-30       Impact factor: 2.651

4.  Suspected reinfections of SARS-COV-2 in Khyber Pakhtunkhwa, Pakistan - analysis of province-wide testing database.

Authors:  Habab Ali Ahmad; Haleema Khan; Muhammad Shahzad; Zia Ul Haq; Steve Harakeh; Yasar Mehmood Yousafzai
Journal:  J Infect       Date:  2021-10-09       Impact factor: 6.072

Review 5.  SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Robert Krause; John P A Ioannidis
Journal:  Environ Res       Date:  2022-02-08       Impact factor: 8.431

Review 6.  Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences.

Authors:  Maria Madeleine Rüthrich; Nicola Giesen; Sibylle C Mellinghoff; Christina T Rieger; Marie von Lilienfeld-Toal
Journal:  Vaccines (Basel)       Date:  2022-01-25

7.  Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis.

Authors:  Mohammad-Mehdi Mehrabi Nejad; Fatemeh Moosaie; Hojat Dehghanbanadaki; Abdolkarim Haji Ghadery; Mahya Shabani; Mohammadreza Tabary; Armin Aryannejad; SeyedAhmad SeyedAlinaghi; Nima Rezaei
Journal:  Eur J Med Res       Date:  2022-02-12       Impact factor: 2.175

8.  Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing.

Authors:  Yael Gurevich; Yoav Ram; Lilach Hadany
Journal:  Evol Med Public Health       Date:  2022-04-18

9.  One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.

Authors:  Chloé Dimeglio; Fabrice Herin; Marcel Miedougé; Isabelle Da-Silva; Marion Porcheron; Guillaume Martin-Blondel; Jean-Marc Soulat; Jacques Izopet
Journal:  J Infect       Date:  2021-06-18       Impact factor: 38.637

Review 10.  COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.

Authors:  Annika Fendler; Elisabeth G E de Vries; Corine H GeurtsvanKessel; John B Haanen; Bernhard Wörmann; Samra Turajlic; Marie von Lilienfeld-Toal
Journal:  Nat Rev Clin Oncol       Date:  2022-03-11       Impact factor: 65.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.